Opa1 is essential for retinal ganglion cell synaptic architecture and connectivity

Brain

Volumn 135, Issue 2, 2012, Pages 493-505

  Williams, Pete A ^a   Piechota, Malgorzata ^a   Von Ruhland, Christopher ^a   Taylor, Elaine ^a   Morgan, James E ^a,b   Votruba, Marcela ^a,b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

connectivity; mitochondria; Opa1; retinal ganglion cell; synapse

Indexed keywords

4 AMINOBUTYRIC ACID; MITOCHONDRIAL PROTEIN; PROTEIN OPA1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; GABAERGIC TRANSMISSION; IMMUNOHISTOCHEMISTRY; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; OPTIC NERVE; PRIORITY JOURNAL; RETINA DISEASE; RETINA GANGLION CELL; RETINA INNER PLEXIFORM LAYER; RETINAL GANGLION CELL DENDROPATHY; SYNAPSE VESICLE; SYNAPTIC TRANSMISSION;

EID: 84857214303     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awr330     Document Type: Article

References (41)

1. Abou-Sleiman PM, Muqit MMK, Wood NW. Expanding insights of mitochondrial dysfunction in Parkinson's disease. Nat Rev Neurosci 2006; 7: 207-19. (Pubitemid 43292466)
2. Amati-Bonneau P, Milea D, Bonneau D, Chevrollier A, Ferré M, Guillet V, et al. OPA1-associated disorders: phenotypes and pathophysiology. Int J Biochem Cell Biol 2009; 41: 1855-65.
3. Barnard AR, Issa PC, Perganta G, Williams PA, Davies V, Sekaran S, Votruba M, MacLaren RE. Specific deficits in electrophysiology in a mouse model of dominant optic atrophy. Exp Eye Res 2011; 93: 771-7.
4. Bodnarenko SR, Jeyarasasingam G, Chalupa LM. Development and regulation of dendritic stratification in retinal ganglion cells by glutamate mediated afferent activity. J Neurosci 1995; 15: 7037-45.
5. Carelli V, Chiara , Valentino ML, Barboni P, Ross-Cisneros FN, Sadun AA. Retinal ganglion cell neurodegeneration in mitochondrial inherited disorders. Biochim Biophys Acta 2009; 1787: 518-28.
6. Carelli V, Ross-Cisneros FN, Sadun AA. Optic nerve degeneration and mitochondrial dysfunction: genetic and acquired optic neuropathies. Neurochem Int 2002; 40: 573-84. (Pubitemid 34159159)
7. Chen H, Chan DC. Critical dependence of neurons on mitochondrial dynamics. Curr Opin Cell Biol 2006; 18: 453-9. (Pubitemid 44016054)
8. Cheng AW, Hou Y, Mattson MP. Mitochondria and neuroplasticity. Asn Neuro 2010; 2: 243-56.
9. Chetkovich DM, Bunn RC, Kuo S-H, Kawasaki Y, Kohwi M, Bredt DS. Postsynaptic targeting of alternative postsynaptic density-95 isoforms by distinct mechanisms. J Neurosci 2002; 22: 6415-25. (Pubitemid 35386398)
10. Cho D-H, Nakamura T, Lipton SA. Mitochondrial dynamics in cell death and neurodegeneration. Cell Mol Life Sci 2010; 67: 3435-47.
11. Davies V, Votruba M. Focus on molecules: the OPA1 protein. Exp Eye Res 2006; 83: 1003-4. (Pubitemid 44404131)
12. Davies VJ, Hollins AJ, Piechota MJ, Yip W, Davies JR, White KE, et al. Opa1 deficiency in a mouse model of autosomal dominant optic atrophy impairs mitochondrial morphology, optic nerve structure and visual function. Hum Mol Genet 2007; 16: 1307-18. (Pubitemid 47055126)
13. Delettre C, Lenaers G, Pelloquin L, Belenguer P, Hamel CP. OPA1 (Kjer type) dominant optic atrophy: a novel mitochondrial disease. Mol Genet Metabol 2002; 75: 97-107. (Pubitemid 34975762)
14. Ferré M, Amati-Bonneau P, Tourmen Y, Malthiery Y, Reynier P. eOPA1: an online database for OPA1 mutations. Human Mutat 2005; 25: 423-8.
15. Frank S, Gaume B, Bergmann-Leitner ES, Leitner WW, Robert EG, Catez F, et al. The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis. Dev Cell 2001; 1: 515-25. (Pubitemid 33586103)
16. Kieper N, Holmstroem KM, Ciceri D, Fiesel FC, Wolburg H, Ziviani E, et al. Modulation of mitochondrial function and morphology by interaction of Omi/HtrA2 with the mitochondrial fusion factor OPA1. Exp Cell Res 2010; 316: 1213-24.
17. Kjer P, Jensen OA, Klinken L. Histopatholgy of the eye, optic nerve and brain in a case of dominant optic atrophy. Acta Ophthalmol 1983; 61: 300-12. (Pubitemid 13137064)
18. Lascaratos G, Ji D, Wood JPM, Osborne NN. Visible light affects mitocondrial function and induces neuronal death in retinal cell cultures. Vis Res 2007; 47: 1191-201. (Pubitemid 46482624)
19. Li Z, Okamoto K, Hayashi Y, Sheng M. The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 2004; 119: 873-87. (Pubitemid 40017692)
20. Liesa M, Palacin M, Zorzano A. Mitochondrial dynamics in mammalian health and disease. Physiol Rev 2009; 89: 799-845.
21. Mattson MP, Gleichmann M, Cheng A. Mitochondria in neuroplasticity and neurological disorders. Neuron 2008; 60: 748-66.
22. Mattson MP, Magnus T. Ageing and neuronal vulnerability. Nat Rev Neurosci 2006; 7: 278-94.
23. Milea D, Sander B, Wegener M, Jensen H, Kjer B, Jorgensen TM, et al. Axonal loss occurs early in dominant optic atrophy. Acta Ophthalmol 2010; 88: 342-6.
24. Mozdy AD, McCaffery JM, Shaw JM. Dnm1p GTPase-mediated mitochondrial fission is a multi-step process requiring the novel integral membrane component Fis1p. J Cell Biol 2000; 151: 367-79.
25. O'Brien JA, Lummis SCR. Biolistic transfection of neuronal cultures using a hand-held gene gun. Nat Protocol 2006; 1: 977-81.
26. Olichon A, Emorine LJ, Descoins E, Pelloquin L, Brichese L, Gas N, et al. The human dynamin-related protein OPA1 is anchored to the mitochondrial inner membrane facing the inter-membrane space. FEBS Lett 2002; 523: 171-6. (Pubitemid 34786081)
27. Olichon A, Guillou E, Delettre C, Landes T, Arnaune-Pelloquin L, Emorine LJ, et al. Mitochondrial dynamics and disease, OPA1. Biochim Biophys Acta Mol Cell Res 2006; 1763: 500-9. (Pubitemid 44015948)
28. Osborne NN, Lascaratos G, Bron AJ, Chidlow G, Wood JPM. A hypothesis to suggest that light is a risk factor in glaucoma and the mitochondrial optic neuropathies. Br J Ophthalmol 2006; 90: 237-41. (Pubitemid 43163859)
29. Reynolds ES. Use of lead citrate at high pH as an electron opaque stain in electron microscopy. J Cell Biol 1963; 17: 208-12.
30. Santel A, Frank S, Gaume B, Herrier M, Youle RJ, Fuller MT. Mitofusin-1 protein is a generally expressed mediator of mitochondrial fusion in mammalian cells. J Cell Sci 2003; 116: 2763-74. (Pubitemid 36857227)
31. Schmitz SK, Hjorth JJJ, Joemai RMS, Wijntjes R, Eijgenraam S, de Bruijn P, et al. Automated analysis of neuronal morphology, synapse number and synaptic recruitment. J Neurosci Methods 2011; 195: 185-93.
32. Selkoe DJ. Alzheimer's disease is a synaptic failure. Science 2002; 298: 789-91. (Pubitemid 35231524)
33. Sernagor E, Eglen SJ, Wong ROL. Development of retinal ganglion cell structure and function. Prog. Retin Eye Res 2001; 20: 139-74. (Pubitemid 32149926)
34. Surgucheva I, Weisman AD, Goldberg JL, Shnyra A, Surguchov A. Gamma-Synuclein as a marker of retinal ganglion cells. Mol Vis 2008; 14: 1540-8.
35. Votruba M, Moore AT, Bhattacharya SS. Clinical features, molecular genetics, and pathophysiology of dominant optic atrophy. J Med Genet 1998; 35: 793-800. (Pubitemid 28431696)
36. Wang XL, Su B, Siedlak SL, Moreira PI, Fujioka H, Wang Y, et al. Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins. Proc Natl Acad Sci USA 2008; 105: 19318-23.
37. Wataha JC, Lewis JB, Lockwood PE, Hsu S, Messer RL, Rueggeberg FA, Bouillaguet S. Blue light differentially modulates cell survival and growth. J Dent Res 2004; 83: 104-8. (Pubitemid 41713791)
38. Williams PA, Morgan JE, Votruba M. Opa1 deficiency in a mouse model of dominant optic atrophy leads to retinal ganglion cell dendropathy. Brain 2010; 133: 2942-51.
39. Williams PA, Morgan JE, Votruba M. Mouse models of dominant optic atrophy: what do they tell us about the pathophysiology of visual loss? Vis Res 2011; 51: 229-34.
40. Wong WT, Faulkner-Jones BE, Sanes JR, Wong ROL. Rapid dendritic remodeling in the developing retina: dependence on neurotransmission and reciprocal regulation by Rac and Rho. J Neurosci 2000; 20: 5024-36. (Pubitemid 30421706)
41. Yu-Wai-Man P, Griffiths PG, Chinnery PF. Mitochondrial optic neuropathies-disease mechanisms and therapeutic strategies. Prog Retin Eye Res 2011; 30: 81-114.